Clinical Trial Update: Comparison of Pharmacokinetics of and Effect on Systemic VEGF Levels in Age Related Macular Degeneration Patients [Phase 2, Phase 3]

View source ↗

Summary

Clinical Trial Update comparing pharmacokinetics and systemic VEGF changes in adults with age-related macular degeneration during Phase 2/Phase 3 studies.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration

Snippet

Sponsor: East Florida Eye Institute | Conditions: Age Related Macular Degeneration | Phase 2, Phase 3 | Status: UNKNOWN